Skip to content

Clinical trials

Observational Breast Neoplasms trials in Russia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Breast Neoplasms Phase: Observational Country / region: Russia Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20111
20121
20142
20161
20172
20191
20202
20212
20223
20235
20241
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Unknown status6
Active, not recruiting3
Recruiting3
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca6
Tomsk National Research Medical Center of the Russian Academy of Sciences4
Novartis Pharmaceuticals3
Blokhin's Russian Cancer Research Center2
Moscow Clinical Scientific Center2
GlaxoSmithKline1
Meshalkin Research Institute of Pathology of Circulation1
N.N. Petrov National Medical Research Center of Oncology1
OmicsWay Corp.1
Research and Practical Clinical Center for Diagnostics and Telemedicine Technologies of the Moscow Health Care Department1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Breast Neoplasms24
Lung Neoplasms2
Neoplasms2
Brain Diseases1
COVID-191
Colonic Neoplasms1
Endometrial Neoplasms1
Fractures, Bone1
Gastrointestinal Neoplasms1
Melanoma1

Trials

Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.